Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Page

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Biochemical Journal|April 26, 2003
Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cellsEdward McKenzie, Kathryn Young, Margaret Hircock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activityJanine Arts, Peter King, Ann Mariën, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2009
Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitorsPatrick Angibaud, Kristof Van Emelen, Laurence Decrane, et al.
Molecular Cancer Therapeutics|March 26, 2017
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family InhibitorTimothy P S Perera, Eleonora Jovcheva, Laurence Mevellec, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Biochemical Journal|April 26, 2003
Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cellsEdward McKenzie, Kathryn Young, Margaret Hircock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activityJanine Arts, Peter King, Ann Mariën, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2009
Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitorsPatrick Angibaud, Kristof Van Emelen, Laurence Decrane, et al.
Molecular Cancer Therapeutics|March 26, 2017
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family InhibitorTimothy P S Perera, Eleonora Jovcheva, Laurence Mevellec, et al.
Pageof 2